SWM
PRPH

Spire Wealth Management’s ProPhase Labs PRPH Stock Holding History

Spire Wealth Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8
Closed -$518 – 2356
2024
Q1 		$518 Buy
+8
New +$405 ﹤0.01% 2295
2023
Q3 		– Sell
-8
Closed -$581 – 2444
2023
Q2 		$581 Buy
+8
New +$651 ﹤0.01% 2369

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spire Wealth Management's PRPH Position: Q2 2024 in Review

Spire Wealth Management sold out of ProPhase Labs (PRPH) in Q2 2024, closing a stake of 8 shares — an estimated $518 sold.

Spire Wealth Management first reported a position in PRPH in Q2 2023 and held it in 2 quarters. The position peaked at $581 in Q2 2023. 29 funds tracked by Wall St. Rank hold PRPH as of Q2 2024.

  • Spire Wealth Management reported no remaining ProPhase Labs position as of Q2 2024 after selling out during the quarter.
  • Spire Wealth Management sold 8 ProPhase Labs shares in Q2 2024, an estimated $518.
  • Spire Wealth Management first reported a position in ProPhase Labs in Q2 2023 and held it in 2 quarters.
  • Spire Wealth Management's ProPhase Labs position peaked at $581 in Q2 2023.
  • 29 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2024.

Based on Spire Wealth Management's 13F filing for Q2 2024, filed 31 Jul 2024.